CVE-2017-7475
Public on
Last Modified:
Description
The CVE Program describes this issue as:
Cairo version 1.15.4 is vulnerable to a NULL pointer dereference related to the FT_Load_Glyph and FT_Render_Glyph resulting in an application crash.
Additional information
- Bugzilla 1447949: cairo: NULL pointer dereference with a crafted font file
- CWE-476: NULL Pointer Dereference
- FAQ: Frequently asked questions about CVE-2017-7475
Common Vulnerability Scoring System (CVSS) Score Details
Important note
CVSS scores for open source components depend on vendor-specific factors (e.g. version or build chain). Therefore, Red Hat's score and impact rating can be different from NVD and other vendors. Red Hat remains the authoritative CVE Naming Authority (CNA) source for its products and services (see Red Hat classifications).
The following CVSS metrics and score provided are preliminary and subject to review.
Red Hat | NVD | |
---|---|---|
CVSS v3 Base Score | 3.3 | 5.5 |
Attack Vector | Local | Local |
Attack Complexity | Low | Low |
Privileges Required | None | None |
User Interaction | Required | Required |
Scope | Unchanged | Unchanged |
Confidentiality Impact | None | None |
Integrity Impact | None | None |
Availability Impact | Low | High |
CVSS v3 Vector
Red Hat: CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:L
NVD: CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H
Frequently Asked Questions
Why is Red Hat's CVSS v3 score or Impact different from other vendors?
My product is listed as "Under investigation" or "Affected", when will Red Hat release a fix for this vulnerability?
What can I do if my product is listed as "Will not fix"?
What can I do if my product is listed as "Fix deferred"?
What is a mitigation?
I have a Red Hat product but it is not in the above list, is it affected?
Why is my security scanner reporting my product as vulnerable to this vulnerability even though my product version is fixed or not affected?
Not sure what something means? Check out our Security Glossary.
Want to get errata notifications? Sign up here.